#orexigen

[moneyhealthfinance-blog]

Orexigen, Advaxis Tumble into Tuesday’s 52-Week Low Club

Orexigen, Advaxis Tumble into Tuesday’s 52-Week Low Club

March 13, 2018: Here are four stocks trading with heavy volume among 36 equities making new 52-week lows in Tuesday’s session. On the NYSE decliners led advancers by about 3 to 2 and on the Nasdaq, decliners led advancers by about 9 to 5. Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 12% Tuesday and posted a new 52-week low of $ 0.29 after closing Monday at $ 0.33. The stock’s…

View On WordPress

[moneyhealthfinance-blog]

Anthera, Orexigen Submerge in Monday’s 52-Week Low Club

Anthera, Orexigen Submerge in Monday’s 52-Week Low Club

March 12, 2018: Here are four stocks trading with heavy volume among 39 equities making new 52-week lows in Monday’s session. On the NYSE advancers led decliners by around 8 to 7 and on the Nasdaq, advancers led decliners by about the same ratio. Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) traded down about 85% Monday and posted a new 52-week and all-time low of $ 0.40 after closing Friday at $…

View On WordPress

[doitjewelry-blog]

Seth Klarman Buys Stake in Orexigen Therapeutics

Seth Klarman Buys Stake in Orexigen Therapeutics

True to form, Seth Klarman (Trades, Portfolio) purchased a stake in a pharmaceutical company with a sinking stock but a new blockbuster drug ready to push out the door.

Klarman’s The Baupost Group LLC held a total of 25,821,363 shares of Orexigen Therapeutics (OREX), a 17.2% stake in the company, as of Sept. 30, it disclosed Oct. 9. Orexigen had previously announced on Sept. 10 that Baupost had…

View On WordPress

[doitjewelry-blog]

Why Orexigen Therapeutics' Stock Rocketed Higher

Why Orexigen Therapeutics’ Stock Rocketed Higher

What: Shares of the anti-obesity drugmaker Orexigen Therapeutics climbed by as much as 21% on heavy volume today. This rally was sparked by the company’s second-quarter earnings release, where it announced that its flagship fat-fighting pill, Contrave/Mysimba, is now the market leading weight loss medicine with 172,050 prescriptions filled during the three-month period.

Perhaps more…

View On WordPress

[gymprogramblog]

Orexigen Weight-Loss Pill Shows Surprise Heart-Safety Benefit

Orexigen Weight-Loss Pill Shows Surprise Heart-Safety Benefit

Orexigen Weight and sizebyDropping Brand Events Stun Heart-Safety Reward A new numbers were usually culled compared to a relatively timely, period in-between treatment and may adjust as the take up persists in, however for now, the scoop is superb for Orexigen and also its particular weight reduction pill up til now Contrave. The minute Orexigen started to this is, the objective could well be…

View On WordPress

[fatosssecretsfromhome]

Orexigen Gives Positive Updates on its Weight Loss Drug ...

Orexigen Gives Positive Updates on its Weight Loss Drug …

Orexigen Therapeutics (OREX) announced encouraging updates on its weight loss drug, Mysimba. … its Weight Loss Drug. by Zacks Equity Research Published on February 10, 2015 | … Acxiom Selected Data Solution Partner by GlobeOne.

View On WordPress